Aurintricarboxylic acid in a canine model of coronary artery thrombosis.
John Strony(Merck & Co., Inc., Rahway, NJ, USA (United States)), Burt Adelman(Massachusetts General Hospital), Dominik Brands(Virginia Commonwealth University Medical Center), M. Phillips(Hunter Holmes McGuire VA Medical Center), Joel L. Moake(Hunter Holmes McGuire VA Medical Center)
Cited by 78
Related Papers
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
|New England Journal of Medicine|2012|941
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|753
Treatment with Bivalirudin (Hirulog) as Compared with Heparin during Coronary Angioplasty for Unstable or Postinfarction Angina
|New England Journal of Medicine|1995|496
Randomized, Double-blind Comparison of Hirulog Versus Heparin in Patients Receiving Streptokinase and Aspirin for Acute Myocardial Infarction (HERO)
|Circulation|1997|232
Synthesis of basement membrane collagen by cultured human endothelial cells.
|The Journal of Experimental Medicine|1976|208